{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:13:55Z","timestamp":1785726835265,"version":"3.56.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.curtheres.2019.01.008","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T13:05:50Z","timestamp":1549803950000},"page":"27-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Psychiatric and Developmental Effects of Isotretinoin (Retinoid) Treatment for Acne Vulgaris"],"prefix":"10.1016","volume":"90","author":[{"given":"Alessandra","family":"Suuberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2165\/00003495-198428010-00002","article-title":"Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders","volume":"28","author":"Ward","year":"1984","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.curtheres.2019.01.008_bib0002","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1365-4632.2011.05409.x","article-title":"High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life","volume":"51","author":"Cyrulnik","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.curtheres.2019.01.008_bib0003","doi-asserted-by":"crossref","DOI":"10.23736\/S0392-0488.18.05979-5","article-title":"Isotretinoin: the ups are just as troubling as the downs","author":"Truitt","year":"2018","journal-title":"G Ital Dermatol Venereol."},{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0004","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/1203475417719052","article-title":"Association of isotretinoin with depression and suicide: a review of current literature","volume":"22","author":"Oliveira","year":"2018","journal-title":"J Cutan Med Surg"},{"issue":"9","key":"10.1016\/j.curtheres.2019.01.008_bib0005","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/14740338.2017.1344641","article-title":"Psychiatric disorders, acne and systemic retinoids: comparison of risks","volume":"16","author":"Le Moigne","year":"2017","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0006","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/bjd.15668","article-title":"Efficacy and adverse effects of oral isotretinoin for acne: a systematic review","volume":"178","author":"Vallerand","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.curtheres.2019.01.008_bib0007","doi-asserted-by":"crossref","unstructured":"Brzezinski, P., et al. 2017. Adverse effects of isotretinoin: a large, retrospective review. 30(4).","DOI":"10.1111\/dth.12483"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0008","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1468-3083.2011.04439.x","article-title":"Effects of isotretinoin treatment on general psychiatric symptoms, quality of life and social phobia in acne vulgaris patients","volume":"27","author":"Karadag","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0009","doi-asserted-by":"crossref","first-page":"155","DOI":"10.31887\/DCNS.2003.5.2\/rcasagrandetango","article-title":"Psychiatric side effects of medications prescribed in internal medicine","volume":"5","author":"Casagrande Tango","year":"2003","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0010","first-page":"66","article-title":"Accutane (isotretinoin) and psychiatric adverse effects","volume":"168","author":"Wooltorton","year":"2003","journal-title":"CMAJ"},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0011","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4088\/JCP.15com09958","article-title":"Should women of childbearing potential be prescribed valproate? A call to action","volume":"77","author":"Balon","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"10.1016\/j.curtheres.2019.01.008_bib0012","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/pds.3481","article-title":"Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States","volume":"22","author":"Pinheiro","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0013","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1748-720X.2009.00355.x","article-title":"iPLEDGE allegiance to the pill: evaluation of year 1 of a birth defect prevention and monitoring system","volume":"37","author":"Schonfeld","year":"2009","journal-title":"J Law Med Ethics"},{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0014","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000017848","article-title":"Oral retinoids in the treatment of seborrhea and acne","volume":"196","author":"Orfanos","year":"1998","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pnpbp.2007.07.001","article-title":"The neurobiology of retinoic acid in affective disorders","volume":"32","author":"Bremner","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4088\/JCP.10r05993","article-title":"Retinoic acid and affective disorders: the evidence for an association","volume":"73","author":"Bremner","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.curtheres.2019.01.008_bib0017","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00128071-200304070-00005","article-title":"Isotretinoin use and subsequent depression and suicide: presenting the evidence","volume":"4","author":"Hull","year":"2003","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0018","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0890-6238(00)00091-5","article-title":"Vitamin A teratogenicity and risk assessment in the macaque retinoid model","volume":"14","author":"Hendrickx","year":"2000","journal-title":"Reprod Toxicol"},{"issue":"10","key":"10.1016\/j.curtheres.2019.01.008_bib0019","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/bdra.20721","article-title":"The neurobehavioral teratology of retinoids: a 50-year history","volume":"88","author":"Adams","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"5","key":"10.1016\/j.curtheres.2019.01.008_bib0020","first-page":"511","article-title":"Isotretinoin (RoAccutane) embryopathy. A case report","volume":"24","author":"Pilorget","year":"1995","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"9","key":"10.1016\/j.curtheres.2019.01.008_bib0021","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0929-693X(97)88158-4","article-title":"Teratogenic effects of vitamin A and its derivates","volume":"4","author":"Guillonneau","year":"1997","journal-title":"Arch Pediatr"},{"issue":"3","key":"10.1016\/j.curtheres.2019.01.008_bib0022","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3181\/0706-MR-158","article-title":"Retinoid-mediated regulation of mood: possible cellular mechanisms","volume":"233","author":"O'Reilly","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"issue":"5","key":"10.1016\/j.curtheres.2019.01.008_bib0023","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1176\/appi.ajp.162.5.983","article-title":"Functional brain imaging alterations in acne patients treated with isotretinoin","volume":"162","author":"Bremner","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.curtheres.2019.01.008_bib0024","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4161\/derm.15331","article-title":"Isotretinoin and FoxO1: A scientific hypothesis","volume":"3","author":"Melnik","year":"2011","journal-title":"Dermatoendocrinol"},{"issue":"3-4","key":"10.1016\/j.curtheres.2019.01.008_bib0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00687018","article-title":"Isotretinoin teratogenicity. Case report with neuropathologic findings","volume":"65","author":"Hansen","year":"1985","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.curtheres.2019.01.008_bib0026","doi-asserted-by":"crossref","unstructured":"Merlini, L., et al. Mid-hindbrain malformations due to drugs taken during pregnancy. J Child Neurol. 29(4):538-544.","DOI":"10.1177\/0883073812474345"},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0027","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4103\/ijabmr.IJABMR_469_16","article-title":"Retinoic acid embryotpathy","volume":"7","author":"Mondal","year":"2017","journal-title":"Int J Appl Basic Med Res"},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0028","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10024-001-0258-0","article-title":"Temporal bone pathology in fetuses exposed to isotretinoin","volume":"5","author":"Moerike","year":"2002","journal-title":"Pediatr Dev Pathol"},{"issue":"3","key":"10.1016\/j.curtheres.2019.01.008_bib0029","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9394(01)01024-8","article-title":"Ocular side effects possibly associated with isotretinoin usage","volume":"132","author":"Fraunfelder","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.curtheres.2019.01.008_bib0030","first-page":"763","article-title":"Isotretinoin embryopathy. Report of one case","volume":"136","author":"Troncoso","year":"2008","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.curtheres.2019.01.008_bib0031","first-page":"193","article-title":"Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223","volume":"2","author":"Willhite","year":"2000","journal-title":"J Craniofac Genet Dev Biol Suppl"},{"issue":"14","key":"10.1016\/j.curtheres.2019.01.008_bib0032","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJM198510033131401","article-title":"Retinoic acid embryopathy","volume":"313","author":"Lammer","year":"1985","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0033","first-page":"308","article-title":"Isotretinoin: a reappraisal","volume":"18","author":"Conner","year":"1984","journal-title":"Drug Intell Clin Pharm"},{"issue":"6","key":"10.1016\/j.curtheres.2019.01.008_bib0034","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/jog.12644","article-title":"Congenital microtia in a neonate due to maternal isotretinoin exposure 1 month before pregnancy: case report","volume":"41","author":"Shirazi","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0035","first-page":"18","article-title":"The power of Accutane. The benefits and risks of a breakthrough acne drug","volume":"35","author":"Meadows","year":"2001","journal-title":"FDA Consum."},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0036","first-page":"315","article-title":"Retinoic acid alters epithelial differentiation during palatogenesis","volume":"11","author":"Abbott","year":"1991","journal-title":"J Craniofac Genet Dev Biol"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0037","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1096-9926(200102)63:2<65::AID-TERA1011>3.0.CO;2-M","article-title":"13-cis-retinoic acid causes patterning defects in the early embryonic rostral hindbrain and abnormal development of the cerebellum in the macaque","volume":"63","author":"Makori","year":"2001","journal-title":"Teratology"},{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0038","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/tera.1420470108","article-title":"Importance of early exposure to 13- cis retinoic acid to induce teratogenicity in the cynomolgus monkey","volume":"47","author":"Korte","year":"1993","journal-title":"Teratology"},{"issue":"12","key":"10.1016\/j.curtheres.2019.01.008_bib0039","first-page":"28","article-title":"General medical drugs associated with depression","volume":"5","author":"Rogers","year":"2008","journal-title":"Psychiatry (Edgmont)"},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0040","first-page":"237","article-title":"The effect of isotretinoin (RoAccutane) therapy on depression and quality of life of patients with severe acne","volume":"9","author":"Fakour","year":"2014","journal-title":"Iran J Psychiatry"},{"key":"10.1016\/j.curtheres.2019.01.008_bib0041","doi-asserted-by":"crossref","unstructured":"Azoulay, L., et al. Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry 69(4):526-532.","DOI":"10.4088\/JCP.v69n0403"},{"issue":"9","key":"10.1016\/j.curtheres.2019.01.008_bib0042","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/070674379504000915","article-title":"Depression associated with isotretinoin therapy","volume":"40","author":"Byrne","year":"1995","journal-title":"Can J Psychiatry"},{"issue":"7-8","key":"10.1016\/j.curtheres.2019.01.008_bib0043","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1345\/aph.1C415","article-title":"Isotretinoin and psychiatric illness in adolescents and young adults","volume":"37","author":"Enders","year":"2003","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0044","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00045391-200303000-00012","article-title":"Overview of existing research and information linking isotretinoin (Accutane), depression, psychosis, and suicide","volume":"10","author":"O'Donnell","year":"2003","journal-title":"Am J Ther"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2230.2010.03921.x","article-title":"What's new in acne? An analysis of systematic reviews published in 2009-2010","volume":"36","author":"Smith","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0046","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1067\/mjd.2001.117730","article-title":"An analysis of reports of depression and suicide in patients treated with isotretinoin","volume":"45","author":"Wysowski","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.curtheres.2019.01.008_bib0047","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.4088\/JCP.09lr05207blu","article-title":"Isotretinoin and the risk of depression","volume":"70","author":"Thakrar","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.curtheres.2019.01.008_bib0048","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-859X-8-2","article-title":"Isotretinoin and psychopathology: a review","volume":"8","author":"Kontaxakis","year":"2009","journal-title":"Ann Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0049","first-page":"8","article-title":"Questions & answers. Does the acne drug, isotretinoin (Accutane), cause depression and suicide, or are the psychiatric risk exaggerated?","volume":"22","author":"Miller","year":"2005","journal-title":"Harv Ment Health Lett"},{"issue":"47","key":"10.1016\/j.curtheres.2019.01.008_bib0050","first-page":"2341","article-title":"Psychiatric symptoms during isotretinoin therapy","volume":"147","author":"van Broekhoven","year":"2003","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0051","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1067\/mjd.2002.12","article-title":"Isotretinoin (Accutane) and serious psychiatric adverse events","volume":"48","author":"O'Connell","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.curtheres.2019.01.008_bib0052","doi-asserted-by":"crossref","unstructured":"Jacobs, D. G., N. L. Deutsch, and M. Brewer. Suicide, depression, and isotretinoin: is there a causal link? J Am Acad Dermatol. 45(5):S168-75.","DOI":"10.1067\/mjd.2001.118233"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0053","first-page":"184","article-title":"Dermatologists' attitudes, prescription, and counseling patterns for isotretinoin: a questionnaire-based study","volume":"14","author":"Nagler","year":"2015","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"10.1016\/j.curtheres.2019.01.008_bib0054","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1468-3083.2009.03313.x","article-title":"Depressive symptoms and suicidal ideation during isotretinoin treatment: a 12-week follow-up study of male Finnish military conscripts","volume":"23","author":"Rehn","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.curtheres.2019.01.008_bib0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.euroneuro.2005.11.006","article-title":"Increased use of mental health services related to isotretinoin treatment: a 5-year analysis","volume":"16","author":"Friedman","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.curtheres.2019.01.008_bib0056","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaad.2010.06.040","article-title":"Effective monitoring of isotretinoin safety in a pediatric dermatology population: a novel \"patient symptom survey\" approach","volume":"65","author":"Hodgkiss-Harlow","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.curtheres.2019.01.008_bib0057","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0151-9638(10)70030-2","article-title":"Isotretinoin, depression and medias","volume":"137","author":"Wolkenstein","year":"2010","journal-title":"Ann Dermatol Venereol."},{"issue":"98","key":"10.1016\/j.curtheres.2019.01.008_bib0058","first-page":"242","article-title":"Isotretinoin: psychiatric disorders","volume":"17","year":"2008","journal-title":"Prescrire Int"},{"key":"10.1016\/j.curtheres.2019.01.008_bib0059","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2050-6511-15-54","article-title":"Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011","volume":"15","author":"Thomas","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00004850-200501000-00008","article-title":"Affective psychosis following Accutane (isotretinoin) treatment","volume":"20","author":"Barak","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.curtheres.2019.01.008_bib0061","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaad.2016.12.028","article-title":"Isotretinoin for acne and risk of depression: a systematic review and meta-analysis","volume":"76","author":"Huang","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.curtheres.2019.01.008_bib0062","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1111\/jdv.14139","article-title":"No evidence for increased anxiety in acne patients treated with isotretinoin","volume":"31","author":"Huang","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 1","key":"10.1016\/j.curtheres.2019.01.008_bib0063","first-page":"S54","article-title":"Isotretinoin and depressive symptoms in patients with severe and recurrent acne","volume":"53","author":"Rubio-Garcia","year":"2015","journal-title":"Rev Med Inst Mex Seguro Soc"},{"issue":"5","key":"10.1016\/j.curtheres.2019.01.008_bib0064","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archderm.141.5.557","article-title":"Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study","volume":"141","author":"Chia","year":"2005","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.curtheres.2019.01.008_bib0065","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2340\/00015555-1638","article-title":"Anxiety, depression, quality of life and patient satisfaction in acne patients treated with oral isotretinoin","volume":"93","author":"Marron","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0066","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-4632.2009.03806.x","article-title":"Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents","volume":"48","author":"Kaymak","year":"2009","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.curtheres.2019.01.008_bib0067","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/09546630410027472","article-title":"A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin","volume":"15","author":"Ferahbas","year":"2004","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0068","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0190-9622(87)70166-2","article-title":"Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin","volume":"17","author":"Rubinow","year":"1987","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0069","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5498\/wjp.v6.i1.136","article-title":"Isotretinoin was not associated with depression or anxiety: A twelve-week study","volume":"6","author":"Suarez","year":"2016","journal-title":"World J Psychiatry"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0070","first-page":"e227","article-title":"No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort","volume":"14","author":"Cohen","year":"2007","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.curtheres.2019.01.008_bib0071","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jad.2016.06.048","article-title":"Affective disorders as potential complication of anti-acne treatment with isotretinoin: a case series","volume":"204","author":"Hanna","year":"2016","journal-title":"J Affect Disord"},{"issue":"10","key":"10.1016\/j.curtheres.2019.01.008_bib0072","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.136.10.1231","article-title":"Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide","volume":"136","author":"Jick","year":"2000","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.curtheres.2019.01.008_bib0073","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1365-2133.2010.10060.x","article-title":"A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms","volume":"163","author":"McGrath","year":"2010","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.curtheres.2019.01.008_bib0074","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1346-8138.2009.00635.x","article-title":"Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients","volume":"36","author":"Hahm","year":"2009","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.sder.2008.03.005","article-title":"Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review","volume":"26","author":"Marqueling","year":"2007","journal-title":"Semin Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.curtheres.2019.01.008_bib0076","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archderm.141.5.557","article-title":"Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study","volume":"141","author":"Chia","year":"2005","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0077","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5114\/pdia.2014.40921","article-title":"Dermatitis artefacta as a symptom of schizophrenia?","volume":"31","author":"Kepska","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0078","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/0019-5154.174091","article-title":"A case report of isotretinoin-induced manic psychosis","volume":"61","author":"Lucca","year":"2016","journal-title":"Indian J Dermatol"},{"issue":"3","key":"10.1016\/j.curtheres.2019.01.008_bib0079","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4103\/0019-5545.140652","article-title":"Acute psychosis induced by isotretinoin","volume":"56","author":"Rajagopal","year":"2014","journal-title":"Indian J Psychiatry"},{"issue":"1","key":"10.1016\/j.curtheres.2019.01.008_bib0080","first-page":"50","article-title":"Isotretinoin therapy for acne vulgaris and first episode psychosis in an adolescent patient","volume":"46","author":"Valderrama","year":"2017","journal-title":"Rev Colomb Psiquiat"},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0081","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/2045125312470129","article-title":"Psychosis during treatment with isotretinoin","volume":"3","author":"Segmiller","year":"2013","journal-title":"Ther Adv Psychopharmacol"},{"issue":"3","key":"10.1016\/j.curtheres.2019.01.008_bib0082","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2009.09.005","article-title":"Psychiatric reactions to isotretinoin in patients with bipolar disorder","volume":"122","author":"Schaffer","year":"2010","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0083","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5498\/wjp.v5.i2.222","article-title":"Inter-relationships between isotretinoin treatment and psychiatric disorders: depression, bipolar disorder, anxiety, psychosis and suicide risks","volume":"5","author":"Ludot","year":"2015","journal-title":"World J Psychiatry"},{"issue":"47","key":"10.1016\/j.curtheres.2019.01.008_bib0084","first-page":"2341","article-title":"Psychiatric symptoms during isotretinoin therapy","volume":"147","author":"Von Broekhoven","year":"2003","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.curtheres.2019.01.008_bib0085","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2147\/NDT.S14438","article-title":"Obsessive-compulsive disorder with bipolar diathesis following Isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine","volume":"6","author":"Fornaro","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"12","key":"10.1016\/j.curtheres.2019.01.008_bib0086","first-page":"1565","article-title":"Panic attacks in a patient treated with isotretinoin for acne. Report of one case","volume":"134","author":"Poblete","year":"2006","journal-title":"Rev Med Chil"},{"issue":"3","key":"10.1016\/j.curtheres.2019.01.008_bib0087","first-page":"188","article-title":"Depression and panic attack in acne treated with isotretinoin","volume":"38","author":"Alcala Partera","year":"2012","journal-title":"Semergen"},{"issue":"10","key":"10.1016\/j.curtheres.2019.01.008_bib0088","first-page":"974","article-title":"Erectile dysfunction during isotretinoin therapy","volume":"29","author":"Tirado Sanchez","year":"2005","journal-title":"Actas Urol Esp"},{"issue":"11","key":"10.1016\/j.curtheres.2019.01.008_bib0089","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00228-011-1067-7","article-title":"Prescribed drugs and violence: a case\/noncase study in the French PharmacoVigilance Database","volume":"67","author":"Rouve","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.curtheres.2019.01.008_bib0090","doi-asserted-by":"crossref","unstructured":"Wu, H., et al. 2016. Developmental neurotoxic effects of percutaneous drug delivery: behavior and neurochemical studies in C57BL\/6 mice. 11(9): e0162570.","DOI":"10.1371\/journal.pone.0162570"},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0091","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00213-011-2611-y","article-title":"Influence of isotretinoin on hippocampal-based learning in human subjects","volume":"221","author":"Ormerod","year":"2012","journal-title":"Psychopharmacology (Berlin)"},{"issue":"14","key":"10.1016\/j.curtheres.2019.01.008_bib0092","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1073\/pnas.0306336101","article-title":"13-Cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice","volume":"101","author":"Crandall","year":"2004","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0093","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ntt.2006.10.008","article-title":"Oral Accutane (13-cis-retinoic acid) has no effects on spatial learning and memory in male and female Sprague-Dawley rats","volume":"29","author":"Ferguson","year":"2007","journal-title":"Neurotoxicol Teratol"},{"issue":"2-3","key":"10.1016\/j.curtheres.2019.01.008_bib0094","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0920-9964(96)88523-9","article-title":"Congenital anomalies in relatives of schizophrenic probands may indicate a retinoid pathology","volume":"19","author":"Goodman","year":"1996","journal-title":"Schizophr Res"},{"issue":"7","key":"10.1016\/j.curtheres.2019.01.008_bib0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-4632.2006.02660.x","article-title":"Isotretinoin and the controversy of psychiatric adverse effects","volume":"45","author":"Strahan","year":"2006","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0096","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2230.2010.03895.x","article-title":"A novel explanation for isotretinoin-induced psychiatric problems and its practical implication","volume":"36","author":"Ghanizadeh","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.curtheres.2019.01.008_bib0097","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0091-3057(96)00284-5","article-title":"Similarities in genetic mental retardation and neuroteratogenic syndromes","volume":"55","author":"Adams","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"10.1016\/j.curtheres.2019.01.008_bib0098","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1651-2227.2010.01711.x","article-title":"Onset of Kleine-Levin Syndrome in association with isotretinoin treatment","volume":"99","author":"Smedje","year":"2010","journal-title":"Acta Paediatr"},{"issue":"6","key":"10.1016\/j.curtheres.2019.01.008_bib0099","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1468-3083.2011.04095.x","article-title":"Effects of isotretinoin treatment on sleep in patients with severe acne: a pilot study","volume":"26","author":"Ismailogullari","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.curtheres.2019.01.008_bib0100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/15622970903449853","article-title":"Genetic vulnerability and isotretinoin-induced psychiatric adverse events","volume":"11","author":"Kontaxakis","year":"2010","journal-title":"World J Biol Psychiatry"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X19300050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X19300050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:58:05Z","timestamp":1757897885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X19300050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":100,"alternative-id":["S0011393X19300050"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2019.01.008","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychiatric and Developmental Effects of Isotretinoin (Retinoid) Treatment for Acne Vulgaris","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2019.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}